Neudle.com: multiple sclerosis clinically isolated syndrome

Differential
(Click to cross reference)

acute disseminated encephalomyelitis

addiction, heroin

addiction, heroin-neurologic complications with

adverse drug reaction

akinetic mute

algorithm

alternating rapid movement

amyloid angiopathy, cerebral

amyloid angiopathy, cerebral, inflammatory type

amyloid beta protein

amyloid beta-related angiitis

aneurysm

aneurysm, internal carotid artery

angiitis

angiitis, granulomatous of CNS

angiitis, isolated of CNS

angiitis, isolated of CNS, benign focal

angiography, cerebral, beaded vessels

angiography, cerebral

angiography, cerebral, false negative

angiography, cerebral, reversible abnormality

antibodies to myelin basic protein

antimyelin antibodies

autoimmune cerebellar ataxia

Barkhof MR criteria for MS

basal ganglia, infarction

basal ganglia, lesion of

brain biopsy, false negative

brain volume

brainstem

brainstem, atrophy

brainstem, infarction of

brainstem, lesion of

bulbar palsy

calcium antagonist

Call-Fleming syndrome

carbamazepine

carbon monoxide poisoning

CAT scan, contrast enhanced, delayed

CAT scan, contrast enhanced, double dose

CAT scan, emission

CAT scan, emission, abnormal

CAT scan, false negative

CAT scan, serial

central nervous system, infection of

central pontine myelinolysis

cerebellar ataxia, primary

cerebellar atrophy, primary

cerebellar atrophy, secondary

cerebellar degeneration

cerebellar lesion

cerebellum

cerebral autosomal dominate arteriopathy with subcortical infarction and leukoencephalopathy

cerebral edema

cerebral edema, vasogenic

cerebral infarction

cerebral infarction, hemorrhagic

cerebral infarction, small, deep

cerebral infarction, subcortical

cerebral venous thrombosis

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrospinal fluid, culture of

cerebrospinal fluid, culture of, viral

cerebrospinal fluid, elevated protein of

cerebrospinal fluid, oligoclonal IgG in

cerebrospinal fluid, protein of

cerebrospinal fluid, red cells in

cerebrovascular accident

cerebrovascular accident, bilateral

cerebrovascular accident, familial occurrence

cerebrovascular accident, multiple

cerebrovascular accident, recurrent

cerebrovascular accident, women

cervical spine

chasing the dragon

chemotherapy, CNS treatment and complications with

children

chin numbness

chromosomal abnormality

Clinical Pathologic Conference(C.P.C.)

cognition

collagen vascular disease

coma

complications

confusion

confusional state, acute

controversies in neurology

cop 1

corpus callosum

corpus callosum, lesion of

degenerative diseases of CNS

dementia

dementia, rapidly progressive

dementia, screening for

demyelinating disease

dental procedure, neurologic complications with

differential diagnosis

diplopia

disability rating scale, neurological

disability, neurological

dizziness

drug abuse

drug abuse, inhalation

drug abuse, neurologic complications of

drug induced neurologic disorders

electroencephalogram, abnormalities of

electromyogram

emotional lability

encephalitis

encephalitis, autoimmune

encephalitis, brainstem

encephalitis, human immunodeficiency virus type 1

encephalitis, viral

encephalopathy

encephalopathy, Hashimoto's

encephalopathy, metabolic

endocarditis

epidemiology of neurology

Epstein-Barr virus

Erdheim-Chester disease

ethics in neurology

evoked potentials

extinction on double simultaneous stimulation

eye movement, disorders of

face, numbness of

facial weakness

facial weakness, bilateral

falling

familial

food-borne infection

fourth ventricle, shift of

gadolinium

gait disorder

gammaglobulin therapy, intravenous

gastroenteritis

gaze palsy

gaze palsy, horizontal

gender

gene mutation

genetic neurologic disorders

gliomatosis cerebri

glutamic acid decarboxylase, antibody

granular osmiphilic material

granulomatous disease

headache, sudden onset of

headache, thunderclap

hearing loss

hearing loss, sudden, unilateral

heel-knee-shin test

hemianopia, homonymous

hemianopia, isolated homonymous

hemiparesis

hepatolenticular degeneration(Wilson's disease)

heralding manifestation

herpes simplex virus

herpes virus

herpes zoster

herpes zoster, ophthalmicus

hiccoughs

histiocytosis

human immunodeficiency virus type 1

human immunodeficiency virus type 1, asymptomatic

hydrocephalus

hydrocephalus, exvacuo

hyperreflexia

hypersomnia

hypertensive encephalopathy

iatrogenic neurologic disorders

immunomodulation

immunosuppressive agents

incoordination

intellectual deficit

intellectual deterioration

internuclear ophthalmoplegia

intracerebral hemorrhage

intracerebral hemorrhage, lobar

intravenous

Jakob-Creutzfeldt disease

Kayser-Fleischer ring

laughing, pathologic

leukoencephalopathy

leukoencephalopathy, differential diagnosis

leukoencephalopathy, toxic

level of consciousness, decreased

limbic encephalitis

listeria monocytogenes

lymphoma involving CNS

lymphoma, primary of CNS

MAGNIMS group

McDonald criteria for MS

medulla oblongata, lesion of

memory, impairment of

meningeal biopsy

meningeal enhancement

meningismus

meningitis, aseptic

mental nerve

mental nerve neuropathy

mental status, abnormal

migraine

mimics

misdiagnosis

mitochondrial disease

MRI, angiography, false negative

MRI, contrast enhanced

MRI, demyelinating disease

MRI, diffusion weighted

MRI, false negative

MRI, field strength

MRI, field strength, high

MRI, incidental finding

MRI, snowball lesions

multiple sclerosis, asymptomatic

multiple sclerosis, children

multiple sclerosis, chronic progressive

multiple sclerosis, clinical patterns

multiple sclerosis, clinically isolated syndrome

multiple sclerosis, conversion to clinically definite

multiple sclerosis, diagnosis of

multiple sclerosis, diagnostic criteria

multiple sclerosis, differential diagnosis of

multiple sclerosis, disability status scale

multiple sclerosis, etiology of

multiple sclerosis, familial

multiple sclerosis, misdiagnosis

multiple sclerosis, monosymptomatic

multiple sclerosis, MRI conversion

multiple sclerosis, MRI criteria

multiple sclerosis, pain in

multiple sclerosis, paroxysmal symptoms in

multiple sclerosis, pathogenesis

multiple sclerosis, preclinical

multiple sclerosis, presenting manifestations

multiple sclerosis, prognosis

multiple sclerosis, prophylaxsis

multiple sclerosis, radiologically isolated syndrome

multiple sclerosis, relapsing

multiple sclerosis, risk factors for

multiple sclerosis, secondary progressive

multiple sclerosis, treatment of

multiple sclerosis, treatment of, first attack

N-acetyl-L-aspartic acid

nausea and vomiting

neoplasm, metastatic

neoplasm, primary intracerebral

neoplasm, primary of CNS

neurologic disease, diagnoses of

neurologic examination, focal

neurologic signs

neurologic symptoms

neuromyelitis optica (Devic's disease)

neuromyelitis optica spectrum disorder

neuroophthalmology

neuropathology

neuroprotective agents

Notch3 gene

numb chin syndrome

nystagmus

nystagmus, primary position of gaze

ocular bobbing

optic nerve, lesion of

optic neuritis

optic neuritis, etiology of

optic neuritis, treatment of

optical coherence tomography

optokinetic nystagmus(O.K.N.)

optokinetic nystagmus, abnormal

osteoblastic lesions, causes of

pain

pain, back

paraneoplastic cerebellar degeneration

Parkinsonism syndrome

paroxysmal neurologic deficits

PAS positive

PAS positive material in the brain

periventricular leukomalacia

personality change

phenylketonuria

pleocytosis of cerebrospinal fluid

pons, infarction of

pons, lesion of

posterior fossa

posterior fossa, lesion of

posterior leukoencephalopathy syndrome

postpartum

practice guidelines

precipitating factors

pregnancy, neurologic complications in

prevention of neurologic disorders

primary lateral sclerosis

prion disease

prognosis

progressive multifocal leucoencephalopathy

progressive neurologic disorder

protein 14-3-3, cerebrospinal fluid

pseudobulbar palsy

psychiatric problems in neurologic disorders

pursuit eye movements, abnormal

pyramidal tract

pyramidal tract dysfunction

quadriparesis

quadriplegia

race

radiation therapy, CNS treatment and complications with

Rankin score

rapidly progressing neurologic illness

Red flags

rehabilitation for neurologic disorders

remote effect of cancer on the nervous system

reversible cerebral vasoconstrictive syndromes

reversible neurologic disorder

review article

rheumatoid arthritis factor(R.A.factor)

rigidity

risk factors

saccadic eye movements, abnormal

scotoma, paracentral-homonymous

sedimentation rate, elevated

seizure

sensorineural hearing loss

serologic testing

sickle cell disease

Sjogren's syndrome

Sjogren's syndrome, neurologic manifestations of

spinal cord, cervical

spinal cord, ischemic lesion of

spinal cord, lesion of

standing difficulty

steroid

steroid therapy, CNS treatment and complications with

subarachnoid hemorrhage

subarachnoid hemorrhage, cerebral convexity

suicide

Susac's syndrome

symmetric brain lesions

symptomatic

systemic lupus erythematosus

systemic lupus erythematosus, neurologic complications with

tandem gait, ataxic

temporal lobe

temporal lobe, lesion

temporal lobe, lesion, bilateral

thyroiditis

tinnitus

tongue, impaired movements of

tonic spasms

toxic encephalopathy

treatment of neurologic disorder

tremor

trigeminal neuralgia

trigeminal neuropathy

trigeminal neuropathy, sensory

vasculitides

vasculopathy

vasoconstrictive drugs

vasospasm, cerebral

ventricular enlargement

visual evoked response

visual field defect

visual symptoms

walking, difficulty with

water channel antibodies

white matter disease, periventricular

work loss

workup

Showing articles 850 to 900 of 4597 << Previous Next >>

Multiple Sclerosis, Side Effects of Interferon Beta Therapy and Their Management
Neurol 53:1622-1627, Walther,E.U.&Hohlfeld,R., 1999

Treatment Recommendations for Interferon-B in Multiple Sclerosis
JNNP 67:561-566, Polman,C.H.,et al, 1999

General Neurologist and Subspecialist Care for Multiple Sclerosis, Patients' Perceptions
Neurol 53:1190-1197, Vickrey,B.G.,et al, 1999

Isolated Cranial Nerve Palsies Due to Brainstem Lesions
Muscle & Nerve 22:1168-1176, Thomke,F., 1999

Interferon-B-1a in Relapsing-Remitting Multiple Sclerosis:Effect on Hypointense Lesion Volume on T1 Weighted Images
JNNP 67:579-584, Gasperini,C.,et al, 1999

Magnetization Transfer Imaging of Patients with Definite MS and Negative Conventional MRI
Neurol 52:845-848, Filippi,M.,et al, 1999

Primary and Transitional Progressive MS,A Clinical and MRI Cross-Sectional Study
Neurol 52:839-845, Stevenson,V.L.,et al, 1999

Development of Hypointense Lesions on T1-Weighted Spin-Echo Magnetic Resonance Images in Multiple Sclerosis,Relation to Inflammatory Activity
Arch Neurol 56:345-351, van Walderveen,M.A.A.,et al, 1999

Clinicopath Conf,Wegener's Granulomatosis with Pachymeningeal Granulomatous Inflammation, Case 9-1999
NEJM 340:945-953, , 1999

Interferon-alpha 2a Reduces MRI Disease Activity in Relapsing-Remitting Multiple Sclerosis
Neurol 52:1049-1056, Myhr,K.M.,et al, 1999

Quantitative MRI in CADASIL, Correlation with Disability and Cognitive Performance
Neurol 52:1361-1367, Dichgans,M.,et al, 1999

Fibromyalgia Syndrome a Decade Later
Arch Int Med 159:777-785, Goldenberg,D.L., 1999

Burden of Migraine in the United States, Disability and Economic Costs
Arch Int Med 159:813-818, Hu,X.H.,et al, 1999

Changes in Resource Use and Outcomes for Patients with Migraine Treated with Sumatriptan, A Managed Care Perspective
Arch Int Med 159:857-863, Lofland,J.H.,et al, 1999

Efficacy, Safety, and Tolerance of the Non-Ergoline Dopamine Agonist Pramipexole in the Treatment of Advanced Parkinson's Disease:A Double Blind, Placebo Controlled, Randomised, Multicentre Study
JNNP 66:436-441, Pinter,M.M.,et al, 1999

Brain Structure and Neurocognitive and Behavioural Function in Adolescents Who Were Born Very Preterm
Lancet 353:1653-1657, Stewart,A.L.,et al, 1999

Relevance of Hypointense Lesions on Fast Fluid-Attenuated Inversion Recovery MR Images as a Marker of Disease Severity in Cases of Multiple Sclerosis
AJNR 20:813-820, Rovaris,M.,et al, 1999

The Relationship of MS to Physical Trauma and Psychological Stress, Report of the Therapeutics and Technology Assessment Subcommittee of the AAN
Neurol 52:1737-1745, Goodin,D.S.,et al, 1999

Trigeminal Neuralgia Triggered by Auditory Stimuli in Multiple Sclerosis
Arch Neurol 56:731-733, Hartmann,M.,et al, 1999

Ibuprofen Treatment Versus Gradual Introduction of Interferon B-1b in patients with MS
Neurol 52:1893-1895, Rice,G.P.A.,et al, 1999

Cavernous Haemangioma Mimicking Multiple Sclerosis
BMJ 318:1604-1605, Cader,M.Z.&Winer,J.B., 1999

Cerebrospinal Fluid Findings in CADASIL
Neurol 53:233, Dichgans,M.,et al, 1999

Lamotrigine Adjunctive Therapy in painful Phenomena in MS:Preliminary Observations
Neurol 53:433, Cianchetti,C.,et al, 1999

Encephalitis after Hepatitis B Vaccination, Recurrent Disseminated Encephalitis or MS?
Neurol 53:396-401, Tourbah,A.,et al, 1999

Multiple Sclerosis in Children Under 6 Years of Age
Neurol 53:478-484, Ruggieri,M.,et al, 1999

Benign Multiple Sclerosis? Clinical Course, Long Term Follow Up, and Assessment of Prognostic Factors
JNNP 67:148-152,138, Hawkins,S.A.&McDonnell,G.V., 1999

Magnetic Resonance Imaging Results of the PRISMS Trial:A Randomized, Double-Blind, Placebo-Controlled Study of Interferon-B1a in Relapsing-Remitting Multiple Scleroosis
Ann Neurol 46:197-206, Li,D.K.B.,et al, 1999

Chronic Thalamic Stimulation for the Tremor of Multiple Sclerosis
Neurol 53:625-628, Montgomery,E.B.,et al, 1999

Intravenous Immunoglobulin Treatment in Neurologic Disorders
Arch Neurol 56:1025-1027,1032, Sorensen,P.S., 1999

Is the Routine Use of Intravenous Immunoglobulin Treatment in Neurologic Disorders Justified?
Arch Neurol 56:1028-1032, Karussis,D.&Abramsky,O., 1999

Recent Advances, Neurology
BMJ 319:362-366, Larner,A.J.&Farmer,S.F., 1999

Adult-Onset Nemaline Myopathy:Another Cause of Dropped Head
Muscle & Nerve 22:1146-1150, Lomen-Hoerth,C.,et al, 1999

Chlamydia Pneumoniae Infection of the Central Nervous System in Multiple Sclerosis
Ann Neurol 46:6-14,4, Sriram,S.,et al, 1999

A Longitudinal Study of Brain Atrophy in Relapsing Multiple Sclerosis
Neurol 53:139-148, Simon,J.H.,et al, 1999

The Contribution of Magnetic Resonance Imaging to the Diagnosis of Multiple Sclerosis
Neurol 53:448-456, Fazekas,F.,et al, 1999

Optic Neuritis as Onset Manifestations of Multiple Sclerosis
Neurol 53:473-478, Sorensen,T.L.,et al, 1999

Association of MS with Thyroid Disorders
Neurol 53:883-885, Karni,A.&Abramsky,O., 1999

Evidence of Interferon B-1a Dose Response In Relapsing-Remitting MS, The OWIMS Study
Neurol 53:679-686, The Once Weekly Interferon for MS Study Group (OWI, 1999

Olfactory Dysfunction in Multiple Sclerosis:Relation to Longitudinal Changes in Plaque Numbers in Central Olfactory Structures
Neurol 53:880-882, Doty,R.L.,et al, 1999

Isolated Trochlear Nerve Palsy in Patients with Multiple Sclerosis
Neurol 53:877-879, Jacobson,D.M.,et al, 1999

Rehabilitation of Persons With Traumatic Brain Injury
JAMA 282:974-983,989, NIH Consensus Development Panel on Rehab with TBI, 1999

Multiple Sclerosis,Therapeutic Update
Arch Neurol 56:277-280, Tselis,A.C.&Lisak,R.P., 1999

Utilization of Unconventional Treatments by Persons with MS:Is It Alternative or Complementary?
Neurol 52:626-629, Schwartz,C.E.,et al, 1999

Neuropsychological Status in Multiple Sclerosis after Treatment with Glatiramer
Arch Neurol 56:319-324, Weinstein,A.,et al, 1999

Quantitative MRI in Patients with Clinically Isolated Syndromes Suggestive of Demyelination
Neurol 52:599-606, Sailer,M.,et al, 1999

Multiple Sclerosis Associated with Uveitis in Two Large Clinic-Based Series
Neurol 52:179-181, Biousse,V.,et al, 1999

Magnetic Resonance Imaging-Based Volumetry Differentiates Idiopathic Parkinson's Syndrome from Multiple System Atrophy and Progressive Supranuclear Palsy
Ann Neurol 45:65-74, Schulz,J.B.,et al, 1999

TI-201 SPECT in Pseudotumoral Multiple Sclerosis
Clin Nucl Med 24:186-188, Obach,V.,et al, 1999

Retinocochleocerebral Vasculopathy
Medicine 77:12-40, Petty,G.W.,et al, 1998

Large Infarcts in the Middle Cerbral Artery Territory, Etiology & Outcome Patterns
Neurol 50:341-350, Heinsius,T.,et al, 1998

Showing articles 850 to 900 of 4597 << Previous Next >>